Skip to main content
OpenTrials

Clinical trial condition

Pantothenate Kinase-associated Neurodegeneration (PKAN)

Explore clinical trials studying Pantothenate Kinase-associated Neurodegeneration (PKAN). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Pantothenate Kinase-associated Neurodegeneration (PKAN) trial results

Recruiting

TIRCON International NBIA Registry

NCT05522374

Conditions
Aceruloplasminemia, Basal Ganglia Diseases, Beta-Propeller Protein-Associated Neurodegeneration (BPAN), +23 more
Locations
  • Children's Hospital of Eastern Ontario, Division of Neurology, Department of Pediatrics Ottawa, Canada
  • Charles University, Department of neurology Prague, Czechia
  • LMU Klinikum, Friedrich-Baur-Institute Munich, Bavaria, Germany
  • The Foundation of the Carlo Besta Neurological Institute, IRCCS Milan, Italy
View Trial Details

Related conditions